| Lsr2 of Mycobacterium Represents a Novel Class of H-NS-Like Proteins BRG Gordon, R Imperial, L Wang, WW Navarre, J Liu Journal of bacteriology 190 (21), 7052-7059, 2008 | 152 | 2008 |
| Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles R Imperial, Z Ahmed, OM Toor, C Erdoğan, A Khaliq, P Case, J Case, ... Molecular cancer 17, 1-7, 2018 | 96 | 2018 |
| Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications R Imperial, OM Toor, A Hussain, J Subramanian, A Masood Seminars in cancer biology 54, 14-28, 2019 | 70 | 2019 |
| Matched whole-genome sequencing (WGS) and whole-exome sequencing (WES) of tumor tissue with circulating tumor DNA (ctDNA) analysis: complementary modalities in clinical practice R Imperial, M Nazer, Z Ahmed, AE Kam, TJ Pluard, W Bahaj, M Levy, ... Cancers 11 (9), 1399, 2019 | 35 | 2019 |
| Profile and Predictors of Blood Tumor Mutational Burden in Advanced Hepatocellular Carcinoma JW Franses, M Lim, AM Burgoyne, K Mody, J Lennerz, J Chang, ... The oncologist 27 (11), e908-e911, 2022 | 8 | 2022 |
| EGFR/ERBB2 amplifications and alterations associated with resistance to lenvatinib in hepatocellular carcinoma M Lim, JW Franses, R Imperial, U Majeed, J Tsai, D Hsiehchen Gastroenterology 164 (6), 1006-1008. e3, 2023 | 7 | 2023 |
| Clinical and Genomic Profile of Primary Cranial Neurolymphomatosis EB Wolf, R Imperial, L Jiang, AK Agarwal, HW Tun Journal of Blood Medicine, 291-303, 2024 | | 2024 |
| Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials R Imperial, O Mosalem, U Majeed, NH Tran, MJ Borad, H Babiker Clinical and Experimental Gastroenterology, 121-134, 2024 | | 2024 |
| A comprehensive analysis of POLE/POLD1 genomic alterations in colorectal cancer O Mosalem, TW Coston, R Imperial, E Mauer, C Thompson, B Yilma, ... The Oncologist, oyae098, 2024 | | 2024 |
| Successful treatment of severe passenger lymphocyte syndrome with efgartigimod synergy RC Chase, AH Koop, M Shaikh, RJ Imperial, DM Harnois, NM Loo, ... Transfusion 64 (4), 755-760, 2024 | | 2024 |
| vatinib in Hepatocellular Carcinoma. Gastroenterology 2023; 164: 1006–1008. e3. While conducting a follow-up study to the above article, the authors identified coding errors … M Lim, JW Franses, R Imperial Gastroenterology, 1, 2024 | | 2024 |
| 829P Age and sex related genomic profiles of follicular lymphoma R Imperial, E Kimbrough, MA Moustafa, A Novak, M Albitar, H Tun Annals of Oncology 34, S545, 2023 | | 2023 |
| Immune checkpoint inhibition in locally advanced rectal adenocarcinoma at Mayo Clinic. RJL Imperial, M Alomari, M Elawady, JC Jones, M DeLeon Journal of Clinical Oncology 41 (16_suppl), e15626-e15626, 2023 | | 2023 |
| Outcomes of peritoneal metastases in mismatch repair deficient (dMMR) cancers treated with immune checkpoint inhibitors and variables associated with response. OM Mosalem, A Elhariri, N Wiest, RJL Imperial, MB Sonbol, Z Jin, ... Journal of Clinical Oncology 41 (16_suppl), e14576-e14576, 2023 | | 2023 |
| Effect of EGFR and ERBB2 amplifications and activating alterations on efficacy of lenvatinib in hepatocellular carcinoma. M Lim, D Yang, RJL Imperial, U Majeed, J Tsai, JW Franses, D Hsieh Journal of Clinical Oncology 41 (4_suppl), 600-600, 2023 | | 2023 |
| B-catenin mutations and the response of advanced hepatocellular carcinoma to immune checkpoint inhibitors. H Mahadevia, RJL Imperial, B Toskich, K Mody Journal of Clinical Oncology 40 (16_suppl), e16124-e16124, 2022 | | 2022 |
| Matched whole-genome sequencing and whole-exome sequencing with circulating tumor DNA (ctDNA) analysis are complementary modalities in clinical practice R Imperial, M Nazer, SG Pappas, T Kuzel, B El-Rayes, T Pluard, M Levy, ... Annals of Oncology 30, v811, 2019 | | 2019 |
| A comprehensive genomic analysis of squamous cell carcinomas of the lung, esophagus, and head and neck. LA Kujtan, P Case, R Imperial, OM Toor, A Khaliq, V Muthukumar, ... Journal of Clinical Oncology 36 (15_suppl), 12123-12123, 2018 | | 2018 |
| Distinct somatic alterations in right-versus left-sided colorectal cancers. R Imperial, Z Ahmed, OM Toor, A Khaliq, N Melton, P Case, J Case, ... Journal of Clinical Oncology 36 (15_suppl), 3592-3592, 2018 | | 2018 |
